Clovis Oncology Current Ratio 2010-2021 | CLVS

Clovis Oncology current ratio from 2010 to 2021. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
Clovis Oncology Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2021-06-30 $0.30B $0.17B 1.70
2021-03-31 $0.25B $0.17B 1.46
2020-12-31 $0.31B $0.19B 1.68
2020-09-30 $0.29B $0.12B 2.33
2020-06-30 $0.32B $0.11B 2.87
2020-03-31 $0.30B $0.12B 2.47
2019-12-31 $0.37B $0.13B 2.75
2019-09-30 $0.42B $0.11B 3.76
2019-06-30 $0.38B $0.11B 3.57
2019-03-31 $0.47B $0.11B 4.39
2018-12-31 $0.57B $0.13B 4.55
2018-09-30 $0.69B $0.08B 9.03
2018-06-30 $0.77B $0.08B 10.03
2018-03-31 $0.56B $0.09B 6.55
2017-12-31 $0.63B $0.08B 7.69
2017-09-30 $0.70B $0.22B 3.19
2017-06-30 $0.72B $0.22B 3.26
2017-03-31 $0.43B $0.06B 7.28
2016-12-31 $0.28B $0.07B 4.26
2016-09-30 $0.33B $0.06B 5.61
2016-06-30 $0.40B $0.07B 5.48
2016-03-31 $0.46B $0.07B 6.28
2015-12-31 $0.54B $0.08B 7.14
2015-09-30 $0.62B $0.08B 8.11
2015-06-30 $0.39B $0.06B 6.22
2015-03-31 $0.44B $0.06B 7.93
2014-12-31 $0.49B $0.05B 10.28
2014-09-30 $0.53B $0.03B 17.00
2014-06-30 $0.28B $0.03B 11.20
2014-03-31 $0.31B $0.02B 12.81
2013-12-31 $0.33B $0.02B 15.68
2013-09-30 $0.36B $0.02B 24.59
2013-06-30 $0.37B $0.01B 31.09
2013-03-31 $0.13B $0.01B 11.35
2012-12-31 $0.15B $0.01B 11.91
2012-09-30 $0.16B $0.01B 13.57
2012-06-30 $0.18B $0.01B 18.07
2012-03-31 $0.12B $0.01B 12.63
2011-12-31 $0.14B $0.01B 12.87
2011-09-30 $0.00B 0.00
2011-06-30 $0.00B 0.00
2011-03-31 $0.00B 0.00
2010-12-31 $0.03B $0.01B 4.73
2009-12-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.526B $0.165B
Clovis Oncology Inc. is a biopharmaceutical company focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. The Company targets its development programs for the treatment of specific subsets of cancer populations. Clovis Oncology Inc. is headquartered in Colorado, USA.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $133.660B 8.90
Bio-Rad Laboratories (BIO.B) United States $23.483B 50.05
QIAGEN (QGEN) Netherlands $12.482B 21.14
Biohaven Pharmaceutical Holding (BHVN) United States $8.764B 0.00
Emergent Biosolutions (EBS) United States $2.892B 6.98
Arcus Biosciences (RCUS) United States $2.573B 0.00
Myovant Sciences (MYOV) United Kingdom $2.051B 0.00
ADC Therapeutics SA (ADCT) Switzerland $2.021B 0.00
Zymeworks (ZYME) Canada $1.443B 0.00
Ambrx Biopharma (AMAM) United States $0.527B 0.00
SQZ Biotechnologies (SQZ) United States $0.417B 0.00
Enzo Biochem (ENZ) United States $0.172B 50.71